Lessons From Biotech Entrepreneurs: Pitching Your First-In-Class Innovation

What does it take to lead a biotech start-up in 2020? Three start-up leaders with companies illustrating different stages of the early biopharma lifecycle give their insights: The role of […]
Femtech Presents Enticing Market Opportunity

The femtech market is expected to see annual revenues of more than $1bn by 2024, growing at a compound annual growth rate of 12.9% according to recent data from consultancy […]
New York City is Not Dead, Our Life Sciences Sector is Thriving

As a born and bred New Yorker, I was disheartened when I read the New York Post op-ed by James Altucher, “NYC is dead forever – here’s why.” I’ve lived […]
A Fireside Chat with J.P. Morgan’s Michael Gaito, Head of Healthcare Investment Banking

J.P. Morgan Chase & Co. is the largest investment bank in the U.S. and the seventh largest in the world, with a strong presence in healthcare. At a recent Demy-Colton […]
Prepping for COVID-19’s Next Wave: Is the Glass Half Full or Half Empty?

COVID-19 didn’t disappear with summer temperatures, it just shifted locations and demographics. Now, with both autumn and flu season fast approaching, nearly everyone is wondering whether we will endure another […]
Lessons From Bergamo: Halting the Complement Cascade May Stop COVID-19 in Its Tracks

Treatments for COVID-19 may be focusing on at the wrong elements of the disease, according to physicians analyzing results from Bergamo, Italy, the epicenter of the pandemic in Europe. They […]
Expert Panel Points to Central Role of Endothelial Injury and Lectin Pathway Activation in Critically Ill COVID-19 Patients
SEATTLE–(BUSINESS WIRE)– Omeros Corporation (Nasdaq: OMER) today announced that the Demy-Colton Virtual Salon Series featured an expert discussion of developments in the treatment of severe COVID-19. The panel session, entitled Lessons from Bergamo: […]
Listening Well And Early To The Signs Of Alzheimer’s Disease

Alzheimer’s disease patients need more therapeutic interventions before they develop severe symptoms even though there are few pharmacological options at the very early stages of the disease, said experts discussing […]
Alzheimer’s Is Not A Silent Disease If You Are Listening

Executive Summary Experts discuss the future of brain health, changing the stereotypical view of an Alzheimer’s patient and how technology and science have evolved the treatment possibilities for dementia patients […]
Alzheimer’s Drugs on Verge of Becoming Mainstream Medicine, but Early Intervention Still is Needed

Diagnostics and therapeutics for Alzheimer’s disease are on the verge of becoming mainstream medicine. It’s about time, too. This neurodegenerative disease is creating a crisis in healthcare, with a bill […]